Yüklüyor......
Immune checkpoint pathways in non-small cell lung cancer
Immunotherapy has evolved at a phenomenal pace in cancer therapeutics. This has primarily been fueled by the much perceived necessity to procure an alternative to current standard of care chemotherapy agents, owing to several concerns such as treatment-related toxicity and poor long-term survival as...
Kaydedildi:
| Yayımlandı: | Ann Transl Med |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890048/ https://ncbi.nlm.nih.gov/pubmed/29666811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.09.30 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|